; and (2) submit a report to the Congress on the results of such study. (b) Database (1) In general The Secretary, in coordination with the Administrator of the Drug Enforcement Administration, shall establish and maintain a database of synthetic recreational drugs. (2) Availability The Secretary shall make the information in the database under paragraph (1) publicly available for use in preventing and treating the use of synthetic recreational drugs. (3) Identification of synthetic recreational drugs Beginning not later than 90 days after the date of the enactment of the Synthetic Drug Prevention, Treatment, and Education Act, for purposes of this section, the Secretary shall specify (and update as necessary) a list of substances, each of which shall satisfy the following criteria: (A) The substance is an analogue of a controlled substance (as defined in section 102 of the Controlled Substances Act). (B) The substance is not marketed as a drug (as defined in section 201 of the Federal Food, Drug, and Cosmetic Act). (C) The substance is determined by the Secretary to be marketed for recreational human use, irrespective of claims to the contrary in the labeling and promotion of the substance. Each substance identified on the most recent list specified by the Secretary pursuant to this paragraph is referred to in this section as a synthetic recreational drug . (c) Cannabimimetic agents (1) Outreach campaign Not later than 1 year after the date of enactment of the Synthetic Drug Prevention, Treatment, and Education Act, the Director, in collaboration with the Assistant Secretary for Mental Health and Substance Use, the Director of the National Institute on Drug Abuse, the Director of the National Institutes of Health, and the Administrator of the Drug Enforcement Administration, shall develop and implement a national outreach campaign to educate law enforcement personnel, State and local agencies, health care professionals, community health organizations, parents, youth, and other community members about preventing